The report "Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020", report provides a detailed overview of the major drivers, restraints, opportunities, and trends impacting the global virus filtration market along with the estimates and forecasts of the revenue and market share analysis.
Browse 74 market data Tables and 104 Figures spread through 185 Pages and in-depth TOC on "Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
The global virus filtration market is projected to reach USD 3.25 Billion by 2020 from USD 1.82 Billion in 2015, at a CAGR of 12.3% between 2015 and 2020. The rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. On the other hand stringent government regulations for validation of filtration products and highly consolidated market are the major factors restraining the growth of this market. Asian region and increasing pharmaceutical outsourcing presents high-growth opportunities in this market. Growing adoption of single-use technologies is an upcoming trend in the virus filtration market.
Ask for PDF Brochure :- http://www.marketsandmarkets.com/pdfdownload.asp?id=157281944
This report segments the global virus filtration market by product, application, end user, and geography. The products segments included in the market are, kits and reagents, filtration systems, other products and services. Of these, the kits and reagents product segment accounted for the largest share of the global virus filtration market in 2015.
The application segments included in this report are, biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products. The biologicals forms the largest and fastest-growing application segment in the global virus filtration market by 2020 and vaccines and therapeutics accounted for the major share of global biologicals segment in 2015.
On the basis of end user segments this report is classified into, pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies. Of these, the pharmaceutical & biotechnology companies was the largest and CRO’s are the fastest-growing end user segment in 2015.
Submit here for Speak to Analyst :- http://www.marketsandmarkets.com/speaktoanalyst.asp?id=157281944
The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). The North America region includes U.S. and Canada. Asian regional segment includes, China, Japan, India and RoA. Geographic analysis reveals that North America accounted for the largest share of the global virus filtration market in 2015. Growth in this market can be attributed to the growth of biopharmaceutical industry.
The major players in this market include Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Email: [email protected]
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets